New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 13, 2014
12:06 EDTTSRO, FPRXFive Prime could be close to collaboration deal, says Wells Fargo
Wells Fargo says that after speaking to management, it believes Five Prime Therapeutics (FPRX) may be close to finalizing a collaboration deal with a pharma company relating to its preclinical immunooncology targets. Wells expects a near-term partnership to drive shares of Five Prime higher, and notes TESARO (TRSO) is up around 30% today following its collaboration announcement.
News For FPRX;TSRO From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
March 4, 2015
07:02 EDTTSROTESARO 3.4M share Secondary priced at $51.00
Subscribe for More Information
March 2, 2015
16:22 EDTTSROTESARO files to sell $150M of common stock
Subscribe for More Information
February 23, 2015
06:25 EDTTSROMedivation removed from Focus List at Citigroup
Subscribe for More Information
06:23 EDTTSROCiti ups TESARO price target to $79, adds to focus list
Subscribe for More Information
February 20, 2015
05:53 EDTTSROTESARO price target raised to $50 from $44 at Mizuho
Mizuho raised its price target for TESARO shares to $50 citing increased confidence and market opportunity for niraparib following the company's Q4 results. The firm expects approval for rolapitant in Q3 and reiterates a Buy rating on the stock.
February 19, 2015
16:13 EDTTSROTESARO reports Q4 EPS ($1.33), consensus ($1.03)
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use